Effectiveness of CoronaVac, ChAdOx1, BNT162b2 and Ad26.COV2.S among individuals with prior SARS-CoV-2 infection in Brazil

Thiago Cerqueira-Silva, Jason R. Andrews, Viviane S. Boaventura, Otavio T. Ranzani, Vinicius de Araújo Oliveira, Enny S Paixão, Juracy Bertoldo Júnior, Tales Mota Machado, Matt D.T. Hitchings, Murilo Dorion, Margaret L Lind, Gerson O. Penna, Derek A.T. Cummings, Natalie E Dean, Guilherme Loureiro Werneck, Neil Pearce, Mauricio L. Barreto, Albert I. Ko, Julio Croda, Manoel Barral-Netto
doi: https://doi.org/10.1101/2021.12.21.21268058

Article Information

doi 
https://doi.org/10.1101/2021.12.21.21268058
History 
  • December 27, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Thiago Cerqueira-Silva1,2,*,
  2. Jason R. Andrews3,*,
  3. Viviane S. Boaventura1,2,
  4. Otavio T. Ranzani4,5,
  5. Vinicius de Araújo Oliveira1,2,6,
  6. Enny S Paixão7,
  7. Juracy Bertoldo Júnior2,6,
  8. Tales Mota Machado8,
  9. Matt D.T. Hitchings9,
  10. Murilo Dorion10,
  11. Margaret L Lind10,
  12. Gerson O. Penna11,12,
  13. Derek A.T. Cummings13,14,
  14. Natalie E Dean15,
  15. Guilherme Loureiro Werneck16,
  16. Neil Pearce7,
  17. Mauricio L. Barreto2,6,
  18. Albert I. Ko1,10,
  19. Julio Croda10,17,18,†,‡ and
  20. Manoel Barral-Netto1,2,6,†
  1. 1Instituto Gonçalo Moniz, Fiocruz, Salvador, BA, Brazil
  2. 2Universidade Federal da Bahia, Salvador, BA, Brazil
  3. 3Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA,USA
  4. 4Barcelona Institute for Global Health, ISGlobal, Barcelona, Spain
  5. 5Pulmonary Division, Heart Institute, Hospital das Clínicas, Faculdade de Medicina, São Paulo, SP, Brazil
  6. 6Center for Data and Knowledge Integration for Health - Fiocruz, Salvador, BA, Brazil
  7. 7London School of Hygiene and Tropical Medicine, London, United Kingdom
  8. 8Universidade Federal de Ouro Preto, Ouro Preto, MG, Brazil
  9. 9Department of Biostatistics, College of Public Health & Health Professions, University of Florida, Gainesville, FL, USA
  10. 10Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Heaven, CT, USA
  11. 11Núcleo de Medicina Tropical, Universidade de Brasília, Brasília, DF, Brazil
  12. 12Escola Fiocruz de Governo, Fiocruz Brasília. Brasília, DF, Brazil
  13. 13Department of Biology, University of Florida, Gainesville, FL, USA
  14. 14Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA
  15. 15Department of Biostatistics & Bioinformatics, Rollins School of Public Health, Emory University
  16. 16Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil
  17. 17Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil
  18. 18Fiocruz Mato Grosso do Sul, Fundação Oswaldo Cruz, Campo Grande, MS, Brazil
  1. ↵‡Correspondence to: Prof Julio Croda, Universidade Federal de Mato Grosso do Sul and Fundação Oswaldo Cruz, julio.croda{at}fiocruz.br

  1. ↵* Authors contributed equally

  2. ↵† Authors contributed equally

Back to top
Posted December 27, 2021.
Download PDF
Data/Code
Email
Effectiveness of CoronaVac, ChAdOx1, BNT162b2 and Ad26.COV2.S among individuals with prior SARS-CoV-2 infection in Brazil
Thiago Cerqueira-Silva, Jason R. Andrews, Viviane S. Boaventura, Otavio T. Ranzani, Vinicius de Araújo Oliveira, Enny S Paixão, Juracy Bertoldo Júnior, Tales Mota Machado, Matt D.T. Hitchings, Murilo Dorion, Margaret L Lind, Gerson O. Penna, Derek A.T. Cummings, Natalie E Dean, Guilherme Loureiro Werneck, Neil Pearce, Mauricio L. Barreto, Albert I. Ko, Julio Croda, Manoel Barral-Netto
medRxiv 2021.12.21.21268058; doi: https://doi.org/10.1101/2021.12.21.21268058
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area